Intelligent Bio Solutions Inc. Common Stock (INBS) Stock Price

INBSStock

$1.50−85.44%52W

Market Cap$4.98M

P/E—

PEG Ratio—

Div yield—

Beta4.58

INBS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-55.75%

Price vs S&P 500 (4W)-15.80%

VGM Score64.44

Book Value / Share (Quarterly)$1.90

P/TBV (Annual)2.02x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)49.68%

Cash Flow / Share (Quarterly)$-4.15

Price vs S&P 500 (YTD)-96.19%

Gross Margin (TTM)48.63%

Net Profit Margin (TTM)-294.91%

EPS (TTM)$-9.66

10-Day Avg Trading Volume0.06M

EPS Excl Extra (TTM)$-9.66

Revenue Growth (5Y)16.31%

EPS (Annual)$-8.44

ROI (Annual)-225.57%

Gross Margin (Annual)48.63%

Net Profit Margin (5Y Avg)-742.65%

Cash / Share (Quarterly)$1.37

Revenue Growth QoQ (YoY)35.78%

ROA (Last FY)-104.10%

Revenue Growth TTM (YoY)38.09%

EBITD / Share (TTM)$-7.72

ROE (5Y Avg)-221.10%

Operating Margin (TTM)-297.76%

Cash Flow / Share (Annual)$-4.15

P/B Ratio0.90x

P/B Ratio (Quarterly)1.00x

Net Income / Employee (Annual)$-776,900

EV / Revenue (TTM)0.23x

Net Interest Coverage (TTM)-3.75x

ROA (TTM)-91.24%

EPS Incl Extra (Annual)$-8.44

Current Ratio (Annual)1.44x

Quick Ratio (Quarterly)1.15x

3-Month Avg Trading Volume0.13M

52-Week Price Return-85.44%

Revenue / Employee (TTM)$263,400

Tangible BV / Share (Quarterly)$0.93

P/S Ratio (Annual)1.18x

Asset Turnover (Annual)0.35x

52-Week High$24.90

Operating Margin (5Y Avg)-777.45%

EPS Excl Extra (Annual)$-8.44

26-Week Price Return-45.85%

Quick Ratio (Annual)1.15x

13-Week Price Return-28.94%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)1.44x

Enterprise Value$982,900

Revenue / Share Growth (5Y)-42.52%

Asset Turnover (TTM)0.31x

Revenue / Employee (Annual)$263,400

Inventory Turnover (Annual)4.11x

Pretax Margin (Annual)-295.80%

Cash / Share (Annual)$1.37

3-Month Return Std Dev102.87%

Net Income / Employee (TTM)$-776,900

ROE (Last FY)-225.57%

Net Interest Coverage (Annual)-110.59x

EPS Basic Excl Extra (Annual)$-8.44

Receivables Turnover (TTM)5.84x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-9.66

Receivables Turnover (Annual)5.84x

ROI (TTM)-169.48%

P/S Ratio (TTM)1.18x

Pretax Margin (5Y Avg)-745.08%

Revenue / Share (Annual)$2.86

Tangible BV / Share (Annual)$0.93

Forward P/E0.63x

Price vs S&P 500 (52W)-100.97%

Year-to-Date Return-84.26%

5-Day Price Return-0.66%

EPS Normalized (Annual)$-8.44

ROA (5Y Avg)-95.17%

Net Profit Margin (Annual)-294.91%

Month-to-Date Return-10.18%

Cash Flow / Share (TTM)$-7.57

EBITD / Share (Annual)$-7.77

Operating Margin (Annual)-299.11%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-206.03%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-9.66

P/TBV (Quarterly)2.02x

P/B Ratio (Annual)1.00x

Inventory Turnover (TTM)4.11x

Pretax Margin (TTM)-295.80%

Book Value / Share (Annual)$1.90

Price vs S&P 500 (13W)-31.63%

Beta4.58x

Revenue / Share (TTM)$1.69

ROE (TTM)-170.36%

52-Week Low$1.35

vGradeA

gGradeB

mGradeD

vgmGradeB

INBS Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 19, 2026	-$1.58	-$0.90	+43.04%(+$0.68)
Q1 2026	May 13, 2026	—	-$1.80	—

INBS Analyst Recommendations

Mar 2025

Jul 2026

Aug 2026

Sep 2026

4.29

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
INBSIntelligent Bio Solutions Inc. Common Stock	A	B	D	1.2x	16.3%	48.6%	-297.8%	$1.50
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Intelligent Bio Solutions Inc. Common Stock

Intelligent Bio Solutions Inc. is a life sciences company developing non-invasive diagnostic tests, including a biosensor platform for chronic disease monitoring and a portable drug screening solution that analyzes fingerprint sweat. The company's products offer real-time, hygienic alternatives to traditional diagnostic and substance screening methods. It operates across four geographic segments—United Kingdom, Asia Pacific, Americas, and Rest of World—with the United Kingdom representing its largest revenue source.